Christie’s is presenting its Non-Fungible Token (NFT) auction – ‘Cartography of the Mind’ – to raise funds for the Multidisciplinary Association for Psychedelic Studies (MAPS).
Clerkenwell Health is expanding its pan-European advisory board with the addition of Dr David Erritzoe, Dr Dea Siggaard Stenbæk, Dr Kim Kuypers and Dr James Stone...
UK-based Beckley Psytech and drug discovery company Lophora ApS will be researching New Clinical Entities (NCE’s) to bolster a pipeline of next-generation psychedelic medicines.
UK-startup Clerkenwell Health is opening Europe’s first ever facility to host commercial psychedelic clinical trials in London.
As research into psychedelics continues to grow, a new peer reviewed scientific journal – Psychedelic Medicine – will be launched in 2023 to provide a high-profile...
Pharmadrug has announced it is advancing its opthalmology programme with the selection of its lead DMT analogue as a potential treatment for primary open angle glaucoma...
CYB004 – which is being developed for anxiety disorders – has shown that it has a similar onset of effect and dose profile to IV DMT...
In vivo findings have demonstrated that the amanita muscaria extract – AME-1 – indicate a potential priming effect on the immune system, allowing it to more...
Albert Labs has appointed Professor Robert Britton and Dr Ricardo Jorge Dinis-Oliveira to its scientific advisory board (SAB).
With growing scientific interest in the area of psychedelics, Duke University has launched the Center for Integrated Psychedelic Science (CIPS).